IntelyCare was founded in 2014 by David Coppins, Ike Nnah, and Chris Caulfield. The company has not publicly endorsed plans to participate in an IPO.
IntelyCare is an AI-powered nurse staffing platform that matches workers with open shifts at assisted living facilities, senior care communities, and other healthcare providers. The company has raised more than $150 million in venture capital funding from investors including Janus Henderson Investors, Longitude Capital, Leeds Illuminate, Endeavour Vision, Revelation Partners, and Kaiser Permanente Ventures. IntelyCare announced a valuation of $1.1 billion following a $115 million Series C funding round in 2022.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/06/2022 | Series C | $121.1MM | $xx.xx | $1.11B | Endeavour Vision, Janus Henderson Ivestors, Kaiser Permanente Ventures, Leeds Illuminate, Longitude Capital, Revelation Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,943,716
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Endeavour Vision, Janus Henderson Ivestors, Kaiser Permanente Ventures, Leeds Illuminate, Longitude Capital, Revelation Partners
|
||||||
02/20/2020 | Series B | $36.42MM | $xx.xx | $107.24MM | Endeavour Vision, Generator Ventures, Kaiser Permanente Ventures | |
Price per Share
$xx.xx
Shares Outstanding
13,186,057
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Endeavour Vision, Generator Ventures, Kaiser Permanente Ventures
|
||||||
11/01/2018 | Series A | $11.55MM | $xx.xx | $27MM | Bill Mantzoukas, Leerink Revelation Partners, Longmeadow Capital, Lrvhealth | |
Price per Share
$xx.xx
Shares Outstanding
10,310,819
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bill Mantzoukas, Leerink Revelation Partners, Longmeadow Capital, Lrvhealth
|
||||||
12/29/2016 | Series Seed | $3.86MM | $xx.xx | $15.46MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,740,966
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|